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The completion of the mouse and other mammalian genome sequences will provide necessary, but not sufficient,
knowledge for an understanding of much of mouse biology at the molecular level. As a requisite next step in this
process, the genes in mouse and their structure must be elucidated. In particular, knowledge of the transcriptional
start site of these genes will be necessary for further study of their regulatory regions. To assess the current state of
mouse genome annotation to support this activity, we identified several hundred gene predictions in mouse with
varying levels of supporting evidence and tested them using RACE–PCR. Modifications were made to the procedure
allowing pooling of RNA samples, resulting in a scaleable procedure. The results illustrate potential errors or
omissions in the current 5 end annotations in 58% of the genes detected. In testing experimentally unsupported
gene predictions, we were able to identify 58 that are not usually annotated as genes but produced spliced
transcripts (∼25% success rate). In addition, in many genes we were able to detect novel exons not predicted by any
gene prediction algorithms. In 19.8% of the genes detected in this study, multiple transcript species were observed.
These data show an urgent need to provide direct experimental validation of gene annotations. Moreover, these
results show that direct validation using RACE–PCR can be an important component of genome-wide validation. This
approach can be a useful tool in the ongoing efforts to increase the quality of gene annotations, especially
transcriptional start sites, in complex genomes.
[Supplemental material is available online at www.genome.org. The sequence data from this study have been submit-
ted to dbEST/GenBank under accession nos. CV303589–CV309218.]
The sequence of the human genome has been completed, and
the mouse genome is rapidly nearing completion (Lander et al.
2001; Venter et al. 2001; Waterston et al. 2002). An important
next step is defining the mammalian gene set and accurate an-
notation of gene structures. There are currently two major sets of
mammalian gene annotations found at Ensembl and National
Center for Biotechnology Information (NCBI).
A canonical set of mouse genes is rapidly coalescing, and
similar progress is also being made on other species. Programs
contributing to this progress, at both Ensembl and NCBI, make
use of full-length cDNAs and add the genes predicted by ab initio
algorithms such as Genscan (Burge and Karlin 1997) and Twin-
scan (Yeh et al. 2001). However, these predictions are further
filtered by Ensembl, which requires additional support such as
multiple EST matches or similarity to genes in another species
before pure predictions rise to the status of confirmed genes.
Thus, the sequencing of full-length cDNAs by the Mammalian
Gene Collection (MGC) and the RIKEN group (Carninci et al.
2002, 2003; Waterston et al. 2002) has greatly improved the an-
notation quality of the mammalian genome. However, these ap-
proaches can miss the genes expressed in a restricted manner or
at very low levels. This conservative approach results in a very
low false-positive rate. However, its sensitivity, the probability of
missing real genes, is less clear and is one of the questions that we
set out to address.
Current gene predictions and annotation also focus largely
on predicting and confirming coding regions. Transcriptional
start sites (TSSs) have been identified for some genes by full-
length cDNA approaches. Other efforts such as the MGC (http://
mgc.nci.nih.gov/) do not attempt to identify the TSS, but have
as their end goal confirming and providing the coding region
of the gene. Even if some percentage of the genes in the MGC
were to actually contain the TSS, since the collection is not de-
signed to contain the TSS one could not know a priori which
were in fact complete. In fact, at this point it is not even known
what percentage of the MGC contains the TSS. Hence annota-
tions are particularly incomplete in describing the TSS of many
genes.
An important facet of the annotation of any genome is the
determination of the TSSs of both coding and noncoding RNA
genes. Even for many well-characterized genes, TSSs are often
unknown. This is of critical importance due to the association
between the TSS and the cis-acting sites that regulate transcrip-
tion. Information about the start sites of all the genes is ulti-
mately required for large-scale computational analysis of se-
quence patterns that are associated with transcriptional regula-
tory themes. A specific example will perhaps clarify this point. If
a set of microarray data indicates that there are several hundred
genes that are expressed together in a pattern, it would be of
interest to search the putative promoters of all of these genes for
common structural motifs. We cannot do this now because of a
lack of a confirmed TSSs for many, perhaps even most, genes.
1These authors contributed equally.
2Corresponding author.
E-mail mccombie@cshl.org; fax (516) 367-8874.
Article and publication are at http://www.genome.org/cgi/doi/10.1101/
gr.3158304.
Letter
2424 Genome Research
www.genome.org
14:2424–2429 ©2004 by Cold Spring Harbor Laboratory Press; ISSN 1088-9051/04; www.genome.org
 Cold Spring Harbor Laboratory Press on November 6, 2017 - Published by genome.cshlp.orgDownloaded from 
Approximately 40% of the known human genes have com-
pletely noncoding first exons (Davuluri et al. 2000). Although a
similar study in mouse has not, to our knowledge, been reported,
one might expect a similar percentage to apply. Due to difficulty
in their purely computational prediction, experimental data are
presently required to determine the location of the promoter or
the 5 end of a transcript.
Here we describe results from a systematic study in which
gene discovery and the understanding of gene structure is ap-
proached by integrating existing gene models and ab initio gene
predictions into an experimental pipeline geared both to identify
the TSSs of known and novel genes and to develop more accurate
gene models. Three hundred genes with varying degrees of asso-
ciated experimental evidence were chosen to test the approach.
The structure of the 5 end of a sizable number of both previously
known and unknown genes was established by using the meth-
ods described here. Based on our results, this approach seems
ideal for validation of a large number of gene predictions, as well
as better annotation of the TSSs in known genes, in a rapid yet
reliable manner.
Results
Gene categorization
The 300 gene predictions or annotated genes selected for analysis
were grouped into five different categories, based on the quality
and quantity of supporting evidence for the gene model (for the
selection process, see Methods and ftp://ftp.cshl.org/pub/
sequences/mouse/data_for_paper/). These gene categories in-
cluded well-characterized genes in the Eukaryotic Promoter Da-
tabase (EPD category), genes from the RefSeq gene set (RefSeq
category), automated gene predictions that are linked to multiple
ESTs/mRNAs, (category B), as well as computational predictions
with a single (category C) or no extant empirical support (cat-
egory D). It should be noted that our goal for inclusion of cat-
egory C and D was to experimentally verify these gene prediction
with much less emphasis on comparison of our experimentally
derived transcript structure with the predicted gene model since
these models are based on limited to no experimental evidence
and therefore will be invariably incomplete at the 5 end. The
category names, definitions, and the number of genes tested in
each are shown in Table 1. A smaller number of genes were as-
signed to the EPD and RefSeq categories since they were origi-
nally intended solely as controls. However, as described below,
interesting data were obtained from their analysis.
Amplification of 5 end of transcripts by RACE–PCR
The result of 5 rapid amplification of cDNA ends (RACE)–PCR on
a set of 15 mouse tissues/stages is shown in Table 1. The RACE–
PCR fragments were cloned, and eight clones for each amplifica-
tion were sequenced. Of the 300 genes in all the categories, 106
were successfully amplified. The genes in the EPD set served as
our internal positive control. All 13 genes in the EPD category
were detected. For all of these genes, at least one splice variant
was detected that agreed with the annotated first exon for the
corresponding gene in the EPD. We amplified from the 5 cap of
the transcript to an internal exon so that the presence of a spliced
product would rule out the possibility of genomic contamina-
tion. Spliced products for a majority of the well-characterized
and curated genes (100% in the EPD and 74% in the RefSeq
categories) were successfully detected.
Fewer of the category C (24%) and D (26%) genes were de-
tected, which was expected based upon a number of possible
hypotheses. For example, the predicted gene may not be ex-
pressed in the tissues/stages tested—which may also be the case
for the 26% of the RefSeq genes as well as the 35% of category B
genes that were also not detected. Alternatively, the gene model
may have an incorrect structure. Finally, the predicted gene may
be a false positive of the prediction algorithm and not truly be an
expressed gene.
Annotation at the 5 ends of genes is incomplete
To assess the quality of current annotations of 5 ends of genes in
the mouse genome, the sequences obtained by 5RACE–PCR were
compared to the corresponding gene annotation/prediction. Se-
quences were filtered using a set of stringent criteria as described
in the Methods section. Table 1 shows the number of genes in the
different categories whose 5 RACE sequences differed from the
gene annotation. Overall, the RACE–PCR method detected 43
first exons that were unannotated/not predicted. Fourteen of
these 43 exons did not have any matching experimental evi-
dence in GenBank (and hence were termed as novel first exons).
Table 1. Description of gene categories
Category Definition
No. of genes
in category
No. of genes
successfully amplified
by 5 RACE (%)
No. of RACE sequences
that differed from the
5 gene annotation (%)
EPD Genes in the Eukaryotic Promoter Database having experimentally
verified transcriptional start sites
13 13 (100%) 4 (31%)
RefSeq NCBI’s curated non-redundant gene set 27 20 (74%) 8 (40%)
B Automated NCBI predictions covered by multiple ESTs 23 15 (65%) 7 (47%)
C Gene predictions which are covered by a single EST only and do
not overlap any mRNA, cDNA, ENSEMBLE or GENIE evidence
169 40 (24%) 30 (75%)
D Gene predictions that do not overlap any EST, mRNA, cDNA,
ENSEMBLE, or GENIE evidence
68 18 (26%) 12 (67%)
Total 300 106 (35%) 61 (58%)
Three hundred mouse genes or gene predictions were classified into five categories based on the quality of associated evidence. The definition column
describes the basis for the classification. Genes in the EPD category have the highest quality evidence and were used as internal positive control for all
experiments. Genes in category D were considered to be based on evidence with least amount of confidence. 5 RACE–PCR was performed on 15 mouse
tissues/stages as described in Methods. The number of genes successfully amplified in each category and satisfying the criteria described in the Methods
section are listed. The number of 5 RACE sequences where the reference sequence annotation was found to be incomplete at the
5 end is shown for each category.
Examination of mouse gene predictions
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Of the 106 genes successfully detected in this study, 61
(58%) produced 5 RACE–PCR sequences that were longer than
the annotation. We analyzed these sequences in relation to their
alignment to their associated gene model or prediction (Fig. 1A).
In 20 of these 61 genes, we found at least one additional exon
upstream of the existing annotation/prediction (Fig. 1B). We ex-
tended the annotated first exon of two genes (15%) in the EPD
and six genes (30%) in the RefSeq categories by an average of 33
and 48 transcribed bases, respectively. EST or similar evidence in
GenBank supported our results concerning all eight of these well-
characterized genes whose annotation was in disagreement with
our results.
Additionally, for two other genes in the EPD category, alter-
native TSSs defining an exon located in the annotated first intron
were detected by RACE–PCR (Fig. 1B). The 5 RACE–PCR se-
quence obtained for the c-myc oncogene (GenBank accession no.
NM_010849) identifies an exon that has supporting evidence in
the form of one EST, and our mapped TSS has previously been
reported as an alternate transcription start site in the EPD data-
base (ID nos. EP14066 and EP14067). However, this exon is not
represented in the RefSeq annotation. In the second case, se-
quence obtained for the myb oncogene (GenBank accession no.
NM_010848) indicates an alternate first exon, which has no ex-
perimental support in GenBank or EPD (see Supplemental Fig. 3).
Interestingly, this exon sequence is conserved in human but not
in Takifugu rubripues. In the case of the RefSeq category, four
genes were observed in which the first exon was located in the
first intronic region. Altogether, we detected 23 cases in all the
categories (Fig. 1B) in which the 5 RACE sequence aligned to
the first intronic region. These findings show the limitations of
current annotation, which must collate various empirical data
sources (such as ESTs) and computer predictions in an attempt to
determine the TSS of a gene.
Comparison of 5 RACE–PCR sequences
with full-length RIKEN cDNA
The RACE–PCR results were compared to full-length RIKEN cDNAs.
Of the 106 genes successfully detected in this study, 54 genes
were represented in the RIKEN full-length cDNA collection. For
each of these 54 genes, at least one RACE–PCR-derived sequence
agreed with the first exon in the corresponding RIKEN cDNA
(although the precise TSSs differed in several cases). However, for
six genes the RACE–PCR approach detected additional first exon
variants that lie in the annotated first intron. These exons are not
represented in the RIKEN collection. This is most likely due to the
presence of alternate first exons, which can be more easily iden-
tified by a directed approach such as RACE–PCR rather than a
sampling approach such as cDNA library construction.
Detection of novel genes
Large-scale studies, including those undertaken by the RIKEN
group and the Mammalian Gene Consortium, have been ex-
tremely valuable in detecting genes (Carninci et al. 2002, 2003;
Waterston et al. 2002). These random-sampling methods suffer,
over time, from decreasing efficiency and increasing costs for
novel gene discovery. To assess the feasibility of using the RACE–
PCR approach to discover novel genes, 237 genes predicted by
Twinscan (Yeh et al. 2001) and GenomeScan (Korf et al. 2001)
programs were tested (genes in categories C and D; Table 1). We
detected products for 58 genes in categories C and D. It is im-
portant to note that the category C and D genes are not presently
considered as annotated genes, suggesting that a targeted analy-
sis of predicted genes has the potential to yield a large increase in
the mammalian gene set.
After the initiation of this study, at least one full-length
cDNA was submitted by the RIKEN group for 28 of the 237 genes
tested in category C and D. Of the 58 category C and D genes that
were detected in this study, nine overlapped with Riken clones.
The TSS suggested by RACE–PCR agreed with that of the RIKEN
clone for all nine genes (data not shown). In addition, eight of
the 237 genes tested in category C and D have subsequently been
annotated as RefSeq genes. However, the RefSeq annotation of
the start sites of four of these eight genes is indicated to be in-
complete by our data.
First exon variation
Identification of variation in first exons is of great importance as
it can potentially help understand gene regulation based on us-
age of alternate promoters and tissue-specific expression (Zhang
et al. 2004). First exon variation is also likely to be involved in the
utilization of alternate splice sites (Zavolan et al. 2002) and there-
fore influence the production of different protein isoforms, par-
ticularly at the amino terminus. In this study, 21 of the 106 genes
(∼20%) successfully detected exhibited variation in transcription
start sites (Fig. 1B). This percentage is similar to that observed by
Zavolan and colleagues wherein 30% of mouse genes in their set
exhibited first exon variation.
CpG island association with first exons
Approximately 50% of genes in mammals are associated with
CpG islands (Antequera and Bird 1993), which have been used as
markers to predict promoter regions. We determined the rela-
Figure 1. Comparison of current 5 annotation with 5 RACE–PCR re-
sults. (A) Schematic representation of the possible alignments of the first
exon suggested by 5 RACE sequence relative to the annotated exons (ex)
and introns (int). (B) Percentage of genes detected in each category
whose 5 RACE sequence exhibits the alignments as follows: first exon is
upstream of the annotated first exon (black), first exon overlaps with
annotated first exon but extends it by at least 20 bp (blue), and first exon
lies completely in the annotated first intronic region or aligns to the
second annotated exon and extends into the first intronic region (light
blue).
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tionship between CpG islands and the first exons detected by
RACE–PCR. The overall percentage of first exons associated with
CpG islands (∼53%) is similar to the previously reported obser-
vation. The first exons for a significantly higher percentage of
genes in the well-characterized set (∼70% in both EPD and RefSeq)
are CpG linked. In contrast, <50% of the first exons of genes in
the other categories were associated with CpG islands (Supple-
mental Fig. 4). This finding may be due to the “types” of genes
that are in the different categories. Specifically, the EPD and RefSeq
categories may consist of a large percentage of constitutively ex-
pressed or housekeeping genes that are known to be associated
with CpG islands at a high frequency (Larsen et al. 1992), while
the other categories may consist of tissue-specific or developmen-
tal stage–specific genes that may have a lower frequency of asso-
ciation with CpG islands.
Discussion
We have carried out a study both to determine the TSSs of a
number of mouse genes and to assess the accuracy of current
mouse genome annotation. The results show that there are con-
siderable deficiencies in the current annotation of TSSs. For 61 of
the 106 genes (58%) successfully amplified (Table 1), 5 RACE–
PCR detected transcripts had incomplete TSS annotation. This is
not surprising, since in the absence of full-length cDNA informa-
tion, the annotation of transcription start sites must collate and
evaluate data from disparate sources, assessing their relative qual-
ity in making a “final” determination of the TSS. We would con-
tend that this is an extremely difficult task. Since a substantial
number of genes are not represented in the publicly available
full-length cDNA sets, the occurrence of misannotated TSSs could
be expected to be very common. Our results suggest that a viable
way to address this issue rigorously is with a systematic program
of directed RACE–PCR based on known gene structures and/or
gene predictions that will aid in “correcting” the existing gene
annotation. Such corrections will be to either capture previously
misannotated structures or, alternately and
importantly, alternate TSSs for correctly an-
notated genes. Such variation in start sites
undoubtedly exists for many genes, and a
directed approach is ultimately probably
the only way to capture it. Only with such
data in hand will we be able to begin carry-
ing out large-scale computational studies
on likely motifs used in the coregulation of
expression of large sets of genes.
In addition, we found that the conser-
vative nature of gene annotation in general
leads to a very low false-positive rate but a
surprisingly high number of missed genes.
It is interesting to note that the current es-
timates of gene numbers in mammalian ge-
nomes is lower than previously thought
(Lander et al. 2001; Venter et al. 2001; Wa-
terston et al. 2002). This runs contrary to
experimental evidence accumulating in the
literature (Shoemaker et al. 2001; Kapranov
et al. 2002; Rinn et al. 2003; Kampa et al.
2004;) as well as the data reported in this
study. It is possible that the emphasis on
database consistency and high specificity is
leading to a substantial underestimate of
gene numbers. As with TSS determination, an effective way to
address this problem is with a systematic experimental confirma-
tion of several types of gene predictions, including those with
low confidence and stringency.
We chose RACE–PCR rather than reverse transcriptase (RT)–
PCR to carry out confirmation of gene predictions for two major
reasons. First, in addition to confirming a transcript, this ap-
proach would provide information about the TSS. Second, the
work of Vidal and colleagues in experimental validation of gene
predictions in C. elegans (Reboul et al. 2001, 2003) showed that a
common cause of failing to recover a transcript from a predicted
gene was that the primer(s) picked from predicted exons were
slightly outside the actual exons. The modified 5RACE–PCR ap-
proach described in this report allows us to have a known primer
(based on the oligo adapter at the 5 end), and the second primer
in an internal exon, which is more reliably predicted using cur-
rent methodologies. We reasoned the overall procedure would be
more robust than using exon-specific primers on both ends.
The optimized 5 RACE–PCR protocol used to obtain the
present data was designed to be performed in a high-throughput
format. Figure 2 provides an overview of the workflow that was
used in this study. Other than the production of 5 RACE cDNA
from specific tissues, all other steps were carried out in 96-well
format with liquid handling performed by the Biomek FX robotic
workstation or a multichannel digital pipettor. Based on the pro-
cedures and workflow we have optimized in the course of this
work, we estimate that two people can obtain 500–1000 5 RACE–
PCR sequences per week.
There are ∼6000 Twinscan and GenomeScan predictions
matching the criteria that we have used for assigning gene pre-
dictions category C and D (ftp://ftp.cshl.org/pub/sequences/
mouse/data_for_paper/). By extrapolation of our gene combined
detection rate in these categories (∼25%), we estimate that there
are likely to be at least 1450 additional genes in the mouse ge-
nome that are not part of the current annotated gene set. Our
results clearly suggest that a significant fraction of the transcrip-
Figure 2. Overview of high-throughput workflow. The initiation of this workflow begins with the
selection of genes for experimental verification. The gene models associated with these genes are
used to select 5 RACE–PCR primers (1st pass) (for more details, see Supplemental information). The
primers are used to amplify RACE templates that have been generated in parallel. Failed amplifi-
cations are identified via agarose gel analysis, and new primers are picked for those genes (2nd
pass). The products of the successful amplification are ligated into a plasmid vector. Eight clones
from every amplification are sequenced and analyzed by comparison to the existing gene model.
Amplified fragments that do not match their associated gene model are evaluated, and new
primers are picked for the associated gene model (2nd pass). Successful matches are further
evaluated in terms of whether they modify the current gene model, and the sequence is submitted
to GenBank.
Examination of mouse gene predictions
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tome may go undetected if gene verification strategies are re-
stricted to testing only those gene predictions that have highly
conserved structures or previous EST matches. It has previously
been reported that three-quarters of all human genes (and by
extrapolation, mouse genes) can be recognized in the Fugu ge-
nome (Aparicio et al. 2002). In contrast, only ∼21% of the 58
novel genes detected in this study have identifiable homologs in
the sequenced Fugu genome. This may show circularity in current
gene annotation efforts that are having the effect of pushing
gene estimates unrealistically downward.
Methods
Three hundred annotated genes or gene predictions were chosen
for analysis. Some of these were selected to allow an evaluation
of the quality of the annotation describing the TSS of well-
characterized genes, while others represent predictions chosen to
allow an estimate of the unannotated genes that might exist
in the genome. Table 1 describes the criteria for categorizing
the genes into different groups based on the quality and confi-
dence level of information associated with each known gene
or gene prediction (for data sources, and detailed information
about gene selection, see Supplemental information; the com-
plete gene set is available at ftp://ftp.cshl.org/pub/sequences/
mouse/data_for_paper/). Briefly, all known (RefSeq and mRNA)
and predicted (Ensembl, GenomeScan, TwinScan) transcripts
were mapped to the mouse genome. For genes in category C and
D, the following steps were taken: (1) genic regions that are only
mapped by GenomeScan and/or TwinScan transcripts (novel
gene set) were selected; (2) from this set, only those predictions
were retained that have at least one FirstEF (Davuluri et al. 2001)
predicted promoter located <20 kb upstream of the 5-boundary;
and (3) all mouse ESTs were mapped to the mouse genome. Pre-
dictions from step 2, which overlap only a single EST, were
placed into category C. Predictions from step 2 that do not over-
lap any EST were placed into category D. (4) Only those genes
from step 3 that have at least one human–mouse conserved se-
quence element (hm-CSE) in the exonic regions were retained,
and (5) the genes in each category were then sorted based on
the distance from the FirstEF predicted TSS to the transcript-
mapped gene 5-end. Two hundred of the category C genes
and 100 of the category D genes with shortest distance were
then used for primer selection. Primers were generated for 237
of these genes based on the primer picking criteria described
below.
Primer design
First exon boundaries were determined by aligning the predicted
sequence to the genome using BLAT (Kent 2002). Primers were
selected within exons other than the first exon to obtain spliced
products. Two primers were chosen for each gene, both in inter-
nal exons, one in the middle of the gene and one flanking the
known or predicted first exon (Supplemental Fig. 5). Perl scripts
were written to design primers using the primer3 software (Rozen
2000). Primers were checked for uniqueness by querying against
a customized database of all mRNA and Riken full-length cDNA
collection. Primers matching sequences other than the corre-
sponding predicted or known mRNA sequences in the custom-
ized database with >70% identity were discarded. For 3RACE–
PCR experiments, two additional primers were picked for each
gene. These primers lie upstream of the two primers picked for 5
RACE–PCR experiments and were designed based on the se-
quences obtained from 5 RACE–PCR experiments for each gene.
Primers were synthesized in 96-well plate format by Illumina or
on site using the Mermade IV oligo-synthesizer.
RACE protocol
Total cytosolic mouse RNA from the following tissues/stages was
obtained from BD Biosciences: 7-, 11-, 15-, and 17-d-total em-
bryo, whole brain, eye, kidney, liver, lung, prostate, submaxilary
gland, smooth muscle, spleen, testes, and uterus. The RACE pro-
tocol was adapted from the RNA-ligase–mediated RACE (RLM–
RACE) system from Ambion. The following modifications were
made to the protocol to increase the robustness and efficiency of
transcript amplification. RNA samples were treated with DNAse I
and purified (Qiagen) prior to the procedure. Following isolation,
10 µg of total RNA was dephosphorylated for 60 min at 37°C in
a 10-µL reaction with 10 U shrimp alkaline phosphatase (SAP;
Roche Diagnostics). RNA was then phenol/chloroform extracted,
precipitated, and resuspended in water; 4.5 µg of dephosphory-
lated RNA was digested for 60 min at 37°C in a 10-µL reaction
with 10 U tobacco acid pyrophosphatase (TAP; Ambion). Nine
hundred nanograms of TAP-digested RNA was then incubated for
60 min at 37°C with 1 U T4 RNA ligase (Ambion) and 17 µM of
an RNA adapter (5GCUGAUGGCGAUGAAUGAACACUGCGUU
UGCUGGCUUUGAUGAAA-3, Ambion). After ligation, 180 ng
of RNA was incubated for 2 min at 75°C in the presence of
5 µM random decamers (Ambion) in RT buffer. The sample was
allowed to cool slowly to room temperature to allow the random
decamers to anneal and prevent the refolding of RNA. Single-
stranded cDNA was generated by the addition of 100 U M-MLV
RT (Ambion) and incubation at 42°C for 60 min.
RACE–PCR amplification
PCR amplification was carried out in 96-well plate format. Am-
plification of 5 RACE cDNA was carried out using nested gene-
specific primers and adapter specific primers. Primers and cycling
conditions are described in Supplemental information.
Cloning and sequencing of RACE–PCR products
After amplification, 5 RACE–PCR products were cloned into
pCR-TOPO2.1 vector (Invitrogen). Briefly, 2 µL PCR reaction was
incubated with 0.1 ng of vector for 30 min at room temperature
in a 96-well PCR plate (Robbins). The ligated samples were then
incubated on ice with 20 µL TOP10 competent cells (Invitrogen)
for 30 min and then heat shocked for 30 sec at 42°C. Cells were
then transferred to 100 µL SOC in a 96-deep well block (Beck-
man-Coulter) and incubated for 1 h at 37°C with shaking. Eight
clones from each transformation were then inoculated in LB me-
dia and grown overnight in a 96-well deep-well plate. DNA was
isolated from the cultures using an automated alkaline lysis prep.
The cloned products were then sequenced using flanking 21
M13 forward and reverse primers in 1/16th Big Dye Terminator
v3.0 reactions (ABI). After precipitation, samples were resus-
pended in water and separated/detected on an ABI 3700 DNA
sequencer.
Sequence analysis
Gene sequences and sequences obtained using the RACE–PCR
method were aligned to the mouse genome (Oct.2003 build) us-
ing BLAT (Kent 2002). For genes in EPD and RefSeq categories,
the latest annotation (RefSeq release 3, January 2004) was used as
the gene sequence. For genes in other categories, the original
gene sequence (corresponding to RefSeq release 2) was used. For
cases in which a corresponding gene structure from RefSeq RNA
Dike et al.
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was not available, the predicted gene structure was used as the
reference annotation. A RACE–PCR sequence was counted as a
positive hit if it satisfied the following criteria: (1) in the case of
multi-exon genes, if alignment indicated a spliced product; (2) if
the product mapped to the same region of the genome as the
gene sequence; (3) if the product could be mapped uniquely to
the genome with >98% identity over >95% of the sequence; (4) if
at least two clones were obtained with similar exon structure; and
(5) if the sequence contained the RACE-specific primer sequence.
Sequences for 15 genes (in categories C and D) did not produce
spliced products but agreed with all the other criteria mentioned
above. Analysis indicated that for all these cases, the primer se-
quences were present in the first exon. For two of these cases,
spliced products were obtained using additional primers and am-
plifying the 3 end of the gene using 3 RACE–PCR. These were
therefore counted as positive hits. The genomic sequence corre-
sponding to the gene and a flanking 15-kb sequence on each side
was extracted. This sequence was used as the reference sequence
to align gene sequence and sequences obtained using the RACE–
PCR method using Sim4 (Florea et al. 1998).
CpG island analysis
Coordinates of CpG islands were obtained from the UCSC (Uni-
versity of California–Santa Cruz) Genome database. A first exon
was considered to be CpG associated if a CpG island overlapped
with a region that lies within 200 bp upstream of the transcrip-
tion start and the first donor sites suggested by RACE–PCR se-
quence.
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